Levels of cerebrospinal fluid apolipoprotein E in patients with Alzheimer's disease and healthy controls

被引:24
作者
Hahne, S [1 ]
Nordstedt, C [1 ]
Ahlin, A [1 ]
Nyback, H [1 ]
机构
[1] KAROLINSKA HOSP, DEPT CLIN NEUROSCI, SECT PSYCHIAT, S-17176 STOCKHOLM, SWEDEN
关键词
cerebrospinal fluid; apolipoprotein E; Alzheimer's dementia; amyloid;
D O I
10.1016/S0304-3940(97)13477-2
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
One isoform of apolipoprotein E (apoE), a protein primarily involved in transport of lipids, is associated with an increased risk for Alzheimer's disease. Moreover, fragments of apoE are deposited in the amyloid that invariantly are found in brain tissue of disease victims. An intriguing possibility is therefore that increased levels of apoE are involved in the pathogenesis of the disease. Levels of full-length apoE in cerebrospinal fluid from 13 Alzheimer patients and 12 healthy controls were determined using Western blotting technique. Levels of the protein were essentially identical to previously reported findings and no difference between patients and healthy controls was found. Hence, it is concluded that increases in cerebrospinal fluid (CSF) levels of apoE are not involved in the pathogenesis of Alzheimer's disease and that measurement of CSF apoE levels does not seem to be useful as a diagnostic procedure. (C) 1997 Elsevier Science Ireland Ltd.
引用
收藏
页码:99 / 102
页数:4
相关论文
共 23 条
[1]   CEREBROSPINAL-FLUID APOLIPOPROTEIN-E IS REDUCED IN ALZHEIMERS-DISEASE [J].
BLENNOW, K ;
HESSE, C ;
FREDMAN, P .
NEUROREPORT, 1994, 5 (18) :2534-2536
[2]   CLINICAL RELEVANCE OF THE QUANTIFICATION OF APOLIPOPROTEIN-E IN CEREBROSPINAL-FLUID [J].
CARLSSON, J ;
ARMSTRONG, VW ;
REIBER, H ;
FELGENHAUER, K ;
SEIDEL, D .
CLINICA CHIMICA ACTA, 1991, 196 (2-3) :167-176
[3]   GENE DOSE OF APOLIPOPROTEIN-E TYPE-4 ALLELE AND THE RISK OF ALZHEIMERS-DISEASE IN LATE-ONSET FAMILIES [J].
CORDER, EH ;
SAUNDERS, AM ;
STRITTMATTER, WJ ;
SCHMECHEL, DE ;
GASKELL, PC ;
SMALL, GW ;
ROSES, AD ;
HAINES, JL ;
PERICAKVANCE, MA .
SCIENCE, 1993, 261 (5123) :921-923
[4]   Apolipoprotein E in cerebrospinal fluid from patients with Alzheimer's disease and other forms of dementia is reduced but without any correlation to the apoE4 isoform [J].
Landen, M ;
Hesse, C ;
Fredman, P ;
Regland, B ;
Wallin, A ;
Blennow, K .
DEMENTIA, 1996, 7 (05) :273-278
[5]   Relevance of the quantification of apolipoprotein E in the cerebrospinal fluid in Alzheimer's disease [J].
Lefranc, D ;
Vermersch, P ;
Dallongeville, J ;
DaemsMonpeurt, C ;
Petit, H ;
Delacourte, A .
NEUROSCIENCE LETTERS, 1996, 212 (02) :91-94
[6]  
LEHTIMAKI T, 1995, HUM GENET, V95, P39
[7]   AMYLOID-ASSOCIATED PROTEINS ALPHA(1)-ANTICHYMOTRYPSIN AND APOLIPOPROTEIN-E PROMOTE ASSEMBLY OF ALZHEIMER BETA-PROTEIN INTO FILAMENTS [J].
MA, JY ;
YEE, A ;
BREWER, HB ;
DAS, S ;
POTTER, H .
NATURE, 1994, 372 (6501) :92-94
[8]   ANTIINFLAMMATORY AGENTS AS A THERAPEUTIC APPROACH TO ALZHEIMERS-DISEASE [J].
MCGEER, PL ;
ROGERS, J .
NEUROLOGY, 1992, 42 (02) :447-449
[9]  
MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939
[10]   CHARACTERIZATION OF STABLE COMPLEXES INVOLVING APOLIPOPROTEIN-E AND THE AMYLOID-BETA PEPTIDE IN ALZHEIMERS-DISEASE BRAIN [J].
NASLUND, J ;
THYBERG, J ;
TJERNBERG, LO ;
WERNSTEDT, C ;
KARLSTROM, AR ;
BOGDANOVIC, N ;
GANDY, SE ;
LANNFELT, L ;
TERENIUS, L ;
NORDSTEDT, C .
NEURON, 1995, 15 (01) :219-228